Allotrope Medical’s StimSite Wins FDA Nod

Allotrope Medical Inc., a company committed to advancing surgical safety and precision, today announced its FDA clearance of their device, StimSite. StimSite provides ob/gyns, general, and colorectal surgeons the new ability to use their existing surgical instruments to help locate and identify ureters using electrical stimulation. Ureter identification is a critical step in safely advancing in operations such as hysterectomies and colon.
 
“Whether it is a gynecologic or colorectal operation, a significant portion of OR time is spent looking for the Ureter and keeping it safe. StimSite provides surgeons with an elegant tool to help rapidly identify the ureter, keep it safe from harm, and promote the progression of a pelvic operation. It should be in the toolbox of every surgeon doing pelvic surgery,” commented Brian Dunkin MD, past president of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES).
 
Alan Greenberg M.D. in Frisco, Texas was the first physician to use StimSite during both laparoscopic and robotic gynecologic procedures. He noted, “StimSite is extremely helpful when trying to find the Ureter, and enables the surgeon to save valuable operating time while making the surgery more efficient and safe.”
 
“With ureter injuries being top of mind for all surgeons operating in the pelvis, we are excited to be able to offer a technology that helps surgeons identify this important structure in a simple and elegant way,” said Albert Huang M.D., Allotrope Medical’s CEO and the inventor of StimSite. “StimSite gives surgeons a new capability to their existing instruments; helping them to provide the best surgical experience for physician and patient alike.”